ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 740

Can Monocyte Chemo-Attractant Protein-1differentiate Different Histological Classes in Lupus Nephritis?

Varun Dhir1, Ranjeeth Kumar Gone2, Amit Sandhu3, Aman Sharma4, Shefali Sharma5, Ritambhra Nada2, Sanjay Jain6 and Manish Rathi7, 1Internal Medicine (Rheumatology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 2Postgraduate Institute of Medical Education and Research, Chandigarh, India, 3Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 4Clinical Immunology and Rheumatology Services, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 5Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 6Postgraduate Institute of Medical Education and Research, Chandigarh, India, CHANDIGARH, India, 7Department of Nephrology,, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Biomarkers, lupus nephritis and nephritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus Nephritis one of the commonest manifestations of SLE. Despite being the gold standard in Lupus nephritis, renal biopsy is an invasive procedure with potential complications and difficult to repeat. Current treatment guidelines prioritize the histological class of lupus nephritis. Monocyte chemo-attractant Protein-1 (MCP-1) a chemokine produced locally during active nephritis was shown in many previous studies as a promising biomarker for activity. This study investigates its usefulness to define histological classes.

Methods: This is a case-control study conducted at a tertiary care center in North India. Cases were patients of SLE satisfying the criteria for active lupus nephritis, defined as proteinuria> 1 gm/24 hours and/or active sediments in the form of hematuria [RBC > 5/hpf] or presence of cellular casts and undergoing kidney biopsy (n=36). Controls were patients of SLE without active LN (less than 500 mg/24 hours proteinuria and no active sediments. These were further divided into Control group I, those who had previously had lupus nephritis and were treated (n=11) and Control group II, those who never had nephritis (n=15)]. Urinary MCP-1 measurement was done using Sandwich ELISA kit. This was normalized for urinary creatinine excretion (pg/mg).

Results: Mean age in cases was 31.1±10.2 years and in control-I was 34.6±8.0 and control II was 36.3±10.4 yrs respectively (p=0.3). Urinary MCP-1 values in cases (1214 ± 1467.1 pg/mg) were significantly higher compared to controls (184.5±186.8 pg/mg, p<0.001). However, no significant difference was observed between control group I (170.5±150.8) and control group II (194±214, p=0.7). Urinary MCP-1 levels showed significant correlation when compared with classical disease markers like 24-hour proteinuria, 24-hour PCR, Spot PCR and SLEDAI. A cut off value of MCP-1 of 339 pg/mg on ROC curve has sensitivity and specificity of 80% and 92% respectively for differentiating active from inactive nephritis. However, there was no significant difference of Urinary MCP-1 levels among different classes of nephritis (p=0.593) (Figure 1). Urinary MCP-1 levels did not show significant correlation with Renal activity index calculated on renal biopsy.

Conclusion: Urinary MCP-1 was not associated with different histological classes of lupus nephritis.

Figure 1: Box-plot depicting Urinary MCP-1 (normalized to urinary creatinine) across various histological classes. Box-plots show median and interquartile range, whiskers denote 1.5xIQR


Disclosure: V. Dhir, None; R. K. Gone, None; A. Sandhu, None; A. Sharma, None; S. Sharma, None; R. Nada, None; S. Jain, None; M. Rathi, None.

To cite this abstract in AMA style:

Dhir V, Gone RK, Sandhu A, Sharma A, Sharma S, Nada R, Jain S, Rathi M. Can Monocyte Chemo-Attractant Protein-1differentiate Different Histological Classes in Lupus Nephritis? [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/can-monocyte-chemo-attractant-protein-1differentiate-different-histological-classes-in-lupus-nephritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/can-monocyte-chemo-attractant-protein-1differentiate-different-histological-classes-in-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology